Reykjavik, Iceland, May 22, 2012
Intellix joint venture Icemedix (name changed to Expeda) with professors Dr. Björn Ludvikson and Dr. Björn Gudbjörnsson at Landspitalet, Reykjavik University Hospital has developed an App for screening individuals for elevated risk for osteoporosis. The medical expert knowledge was captured with the Intellix Designer and a web service was developed by Intellix and hosted in the cloud for powering Expeda’s clinical decision support tool accessed from computers/laptops and smartphone’s via Apps. Intellix have developed both a professional- and a non-professional version for Expeda and the App being introduced today is for the non-professional market.
“What Intellix is doing for Expeda is only one example how easy medical knowledge can be captured and made available for non-professionals (both individuals and general physicians) for improved decision making and cost savings with the Intellix suite of products and we expect to see a big increase in applications in other medical areas were Intellix technology is used in the near future”, said Intellix CEO, Mr. Per Schmidt.
The Expeda Osteoporosis Advisor is an easy to use tool providing individuals and non-professionals with valuable health information on Osteoporosis. The new App is intended to increase public awareness on Osteoporosis and to aid in the screening of Osteoporosis amongst the general public.
“The total cost of osteoporosis related fracture is estimated to be 3.5% of the total and we at Expeda believe that our contribution towards lowering the total cost is considerable” said Expeda CEO, Mr. Thorsteinn Geirsson. Osteoporosis is a disease in which the density and quality of the bone is reduced, resulting in enhanced risk of bone fracture. Osteoporosis is very common affecting about one out of three women and one out of five men worldwide. The loss of bone occurs "silently" and frequently there are no symptoms until the first fracture occurs, e.g. in the wrist, spine or hip. Fractures can have serious consequences, including chronic pain, body deformity, hospitalization, operations and loss of independence. Thus, significantly reducing the individual’s quality of life and in worst cases it can result in death. Today it is known that death rate due to hip fracture is higher compared to breast cancer related mortality among women.
The newly released App is compatible with iPhone 3GS, iPhone 4, iPhone 4S, iPod touch (3rd generation), iPod touch (4th generation) and iPad. / Requires iOS 4.1 or later.
For further information please contact:
Per Schmidt, CEO, Intellix
ps@intellix.com
Thorsteinn Geirsson, CEO, Expeda
thor@expeda.is
Phone: +354 897 9148
www.expedamedical.com